Metastatic pheochromocytoma and paraganglioma: Integrating tumor biology in clinical practice

Keyphrases

• Metastatic Disease 100%
• Clinical Practice 100%
• Tumor Growth 100%
• Tumor Biology 100%
• Metastatic Pheochromocytoma 100%
• Metastatic Paraganglioma 100%
• Tumor 50%
• Significant Risk Factors 50%
• Treatment Options 50%
• Chemotherapy 50%
• Tumor Metastasis 50%
• Remission 50%
• Localized Disease 50%
• Germline mutation 50%
• Pheochromocytoma 50%
• Molecular Pathways 50%
• Life-threatening Complications 50%
• Neuroendocrine Tumor 50%
• Catecholamines 50%
• Therapy Options 50%
• Multikinase Inhibitor 50%
• Rapidly Evolving 50%
• Resistant Hypertension 50%
• Paraganglioma 50%
• Organ Damage 50%
• Autonomic Nervous System 50%
• Chromaffin Cells 50%
• Tumor-derived 50%
• Radiopharmaceutical Agent 50%
• Metastatic PPGL 50%

Medicine and Dentistry

• Metastatic Carcinoma 100%
• Tumor Biology 100%
• Pheochromocytoma 100%
• Paraganglioma 100%
• Tumor Progression 66%
• Immunotherapy 33%
• Somatics 33%
• Chemotherapy 33%
• Tumor 33%
• Neuroendocrine Tumor 33%
• Localized Disease 33%
• Signal Transduction 33%
• Germline Mutation 33%
• Catecholamine 33%
• Radiopharmaceutical Agent 33%
• Autonomic Nervous System 33%
• Chromaffin Cell 33%
• Treatment Option 33%
• Hypertension 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Neoplasm 100%
• Pheochromocytoma 100%
• Paraganglioma 100%
• Tumor Growth 66%
• Diseases 33%
• Immunotherapy 33%
• Remission 33%
• Neuroendocrine Tumor 33%
• Catecholamine 33%
• Radiopharmaceutical Agent 33%
• Chemotherapy Regimen 33%
• Hypertension 33%